Close Menu

NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it will provide as much as $1.9 million in funding to researchers from industry and academia advancing new diagnostic technologies for Alzheimer's disease.

ADDF said it has also partnered with Sage Bionetworks to establish an online repository for biomarker data generated by grant recipients, and that it has committed up to $1.3 million to support development of a mobile app for the early detection of memory problems.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.